Back pain device group Mainstay Medical raises $108m
Funding will drive commercialisation of Reactiv8 in critical US market
Funding will drive commercialisation of Reactiv8 in critical US market
Company secures FDA approval for its flagship medical device called ReActiv8
Mainstay Medical’s flagship product is now eligible for reimbursement from private health funds
Revenue at Irish medical device company targeting chronic back pain almost doubles
‘Day 100’ meeting reviews status of application’s review
Company submits application for pre-market approval to US regulator
Company insists other data support case for its implanted electrical stimulation device
Company awaits data as it looks to roll-out ReActive8 device to patients in the US
Matthew Onaitis joins medical device company from Cidara Therapeutics
Group completes back pain neurostimulator implants in all 204 patients enrolled in test for device
Company says five centres in Germany and Ireland have implanted patients with ReActiv8
Firm aims to bring its new therapy for chronic lower back pain to key US market
Irish company positive about clinical trial stemming from its ReActiv8-B product
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices